Published in
Wiley, Hematological Oncology, 4(37), p. 418-423, 2019
DOI: 10.1002/hon.2619
Links
Tools
Impact of 2016‐WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib
Journal article published in 2019 by
Francesca Palandri 
,
Giuseppe A. Palumbo,
Elisabetta Abruzzese,
Alessandra Iurlo ,
Nicola Polverelli ,
Elena Elli,
Massimiliano Bonifacio,
Micaela Bergamaschi,
Bruno Martino,
Mario Tiribelli,
Giulia Benevolo,
Alessia Tieghi,
Nicola Sgherza,
Alessandro Isidori,
Gianni Binotto
and other authors.
,
Giuseppe A. Palumbo,
Elisabetta Abruzzese,
Alessandra Iurlo ,
Nicola Polverelli ,
Elena Elli,
Massimiliano Bonifacio,
Micaela Bergamaschi,
Bruno Martino,
Mario Tiribelli,
Giulia Benevolo,
Alessia Tieghi,
Nicola Sgherza,
Alessandro Isidori,
Gianni Binotto
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 